Paper Details

  1. Home
  2. Paper Details

Pimavanserin for the treatment of Parkinson's disease psychosis.

Author: FriedmanJoseph H

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This paper discusses the challenges of treating psychotic symptoms, particularly hallucinations and delusions, in patients with Parkinson's disease. Current treatment options have significant drawbacks, highlighting the need for effective and safe treatments for these debilitating side effects.
Paper Details　
Original Abstract of the Article :
Parkinson's disease (PD) is a neurobehavioral disorder defined by its motor features. Its treatment is frequently complicated by the presence of psychotic symptoms, most prominently hallucinations and delusions. These cause major distress and are the primary cause for nursing home placement. Current...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14656566.2013.819345

データ提供：米国国立医学図書館（NLM）

Parkinson's Disease Psychosis: A Mirage in the Desert of the Mind

Parkinson's disease is a debilitating disorder that affects the nervous system, often accompanied by psychotic symptoms that can be difficult to manage. This article focuses on the challenges of treating psychosis in patients with Parkinson's disease and explores the potential of pimavanserin as a novel therapeutic option.

The authors discuss the limitations of current treatment options, including the risk of side effects and the lack of approved medications in the United States. They highlight the potential of pimavanserin, a drug that targets a specific receptor in the brain, as a promising new treatment for Parkinson's disease psychosis.

The Desert of the Mind: Finding Relief from Psychosis

This article provides valuable information about the challenges of managing psychosis in Parkinson's disease and explores the potential of pimavanserin as a new treatment option. The authors emphasize the need for further research to fully evaluate the effectiveness and safety of this drug.

Dr. Camel's Conclusion

Parkinson's disease psychosis is a complex and challenging condition, like a mirage in the desert of the mind. This article offers a ray of hope, exploring the potential of pimavanserin as a new treatment option. The authors highlight the need for further research to explore its efficacy and safety, but offer a glimpse of a potential oasis in the desert of Parkinson's disease psychosis.

Date :
  1. Date Completed 2014-03-25
  2. Date Revised 2016-11-25
Further Info :

Pubmed ID

24016069

DOI: Digital Object Identifier

10.1517/14656566.2013.819345

Related Literature

Article Analysis
・Side Effects of pimavanserin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.